A study of Ketoprofen transdermal (NAL1216) for pain

Trial Profile

A study of Ketoprofen transdermal (NAL1216) for pain

Phase of Trial: Phase I

Latest Information Update: 13 Sep 2016

At a glance

  • Drugs Ketoprofen (Primary)
  • Indications Pain
  • Focus Adverse reactions
  • Most Recent Events

    • 13 Sep 2016 Status changed from recruiting to discontinued, according to information from company website. (Refer http://www.nalpharma.com/licensing.php?id=5&lang=en).
    • 16 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top